Patent Yard Sign in
Expired Canadian patentCanada

Derivatives of 1,2,5-thiadiazole-1-oxides and 1,1- dioxides as histamine h2-antagonists

CA 1263115 C · Owner: Bristol-Myers Squibb Company · Inventors: Algieri, Aldo A.; Crenshaw, Ronnie R.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A compound of the formula, wherein p is 1 or 2; n is an integer of from 2 to 4 inclusive; R2 and R3 each are independently hydrogen (lower)-, alkyl, (lower)alkenyl, (lowerl)alkynyl cyclo(lower)alkyl, cyclo(lower)alkyl(lower)alkyl hydroxy(lower)alkyl, (lower)-, alkoxy(lower)alkyl (lower)alkylthio(lower)alkyl, amino-, (lower)alkyl (lower)alkylamino(lower)alkyl, di(lower)alkylamino(lower)alkyl, pyrrolidino(lower)alkyl piperidino-, (lower)alkyl, morpholino (lower)alkyl piperazino(lower)-, alkyl, pyridyl(lower)alkyl amino, (lower)alkylamino, di(lower)alkylamino 2,2,2-trifiuoroethyl, 2-fluoroethyl, hydroxy (lower)alkoxy, 2,3-dihydroxypropyl, cyano cyano(lower)alkyl, amidino, (lower)alkylamidino …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Granted November 21, 1989. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended November 21, 2006.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 6, 1983
GrantedNovember 21, 1989
Term endedNovember 21, 2006
Patent numberCA 1263115 C
Classification (IPC)C07D285/10 +1 more

Timeline

Timeline From CIPO dates

19841987199019931996199920022005Application filedJuly 6, 1983Patent grantedNov 21, 1989Term endedNov 21, 2006

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.